000 01317 a2200385 4500
005 20250511191224.0
264 0 _c19921022
008 199210s 0 0 eng d
022 _a0009-9236
024 7 _a10.1038/clpt.1992.139
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRane, A
245 0 0 _aEthylmorphine O-deethylation cosegregates with the debrisoquin genetic metabolic polymorphism.
_h[electronic resource]
260 _bClinical pharmacology and therapeutics
_cSep 1992
300 _a257-64 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aDealkylation
650 0 4 _aDebrisoquin
_xpharmacokinetics
650 0 4 _aDextromethorphan
_xmetabolism
650 0 4 _aEthylmorphine
_xmetabolism
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMetabolic Clearance Rate
650 0 4 _aMetabolism
_xgenetics
650 0 4 _aMiddle Aged
650 0 4 _aPolymorphism, Genetic
650 0 4 _aRegression Analysis
700 1 _aModiri, A R
700 1 _aGerdin, E
773 0 _tClinical pharmacology and therapeutics
_gvol. 52
_gno. 3
_gp. 257-64
856 4 0 _uhttps://doi.org/10.1038/clpt.1992.139
_zAvailable from publisher's website
999 _c1532565
_d1532565